Our nine-member Board of Directors and six-member Executive Leadership Team comprise broad and global management experience, comprehensive biotech expertise and in-depth knowledge of Novozymes’ business. The members’ competencies combine to ensure expert management of the company.
LEO Pharma A/S
Holds a Ph.D. and an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU) and a B.Com. in International Business Management from Copenhagen Business School, Denmark.
Novozymes’ CEO since 2013. Peder Holk Nielsen focuses on developing our organization and processes to effectively turn market insights into product ideas and solutions that excite Novozymes’ customers. With his background in engineering and business management, Peder Holk Nielsen drives an agenda that couples market insights and research capabilities to deliver innovation and growth.
Holds an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU), as well as a BA in philosophy and education from Copenhagen University, Denmark.
Tina Sejersgård Fanø is responsible for application research, technical services, sales and marketing in the Agriculture & Bioenergy division. She has significant experience in developing and managing global partnerships and has been instrumental in negotiating several major business deals for Novozymes over the years.
Holds a Ph.D. in Chemical Engineering from the University of Texas at Austin, US.
Andrew Fordyce is responsible for application research, technical services, sales and marketing in the Food & Beverages division. His career has moved from pure engineering to a strong focus on value generation for customers. Previous responsibilities include global sales and marketing, strategic account management and technical service strategy.
Allianz Elementar Versicherungs-AG
Allianz Elementar Lebensversicherungs-AG
Holds a Ph.D. in Business Administration from the Vienna University of Economics and Business, Austria.
As of February 1, 2018, Prisca Havranek-Kosicek has taken up the position of CFO and leads Finance, Legal, IT and Investor Relations. Prisca Havranek-Kosicek has strong business acumen from international positions around the world, a thorough understanding of the different finance functions and knowledge of the markets in which Novozymes operates.
Holds an M.Sc. in Economics from Aarhus University, Denmark.
Anders Lund is responsible for application research, technical services, sales and marketing in the Household Care & Technical division. He has a strong commercial and strategic background as well as extensive experience of building and maintaining global customer relationships.
Holds a Ph.D. and an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU) and a B.Com. in International Business from Copenhagen Business School.
Thomas Videbæk is responsible for Novozymes’ Research, Innovation & Supply unit. The unit has core research at its center and focuses on developing new biological solutions and production optimization – from discovery to large-scale manufacturing. The unit also ensures the supply and quality of our products and incubation of new platforms. Thomas Videbæk has been a central driver of business ventures outside Novozymes’ established areas for several years. He also has broad knowledge of sales and customer solutions and supply chain operations.